CM Hospitalar (BSP:VVEO3) Piotroski F-Score: 8 (As of Jun. 28, 2026) — 167% Above Median


BSP:VVEO3 CM Hospitalar SA BSP:VVEO3
70 GF Score
Price R$0.77
GF Value R$1.99
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is CM Hospitalar Piotroski F-Score?

CM Hospitalar BSP:VVEO3 -37.40% 70 Piotroski F-Score is 8 as of Jun. 28, 2026, which is 167% above its 10-year median of 3.00. GuruFocus rates BSP:VVEO3 with a GF Score™ of 70/100 and a GF Value™ of R$1.99 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 112 Medical Distribution companies, CM Hospitalar ranks better than 97.32% on this metric.

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

CM Hospitalar has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for CM Hospitalar's Piotroski F-Score or its related term are showing as below:

BSP:VVEO3' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 8
Current: 8

During the past 10 years, the highest Piotroski F-Score of CM Hospitalar was 8. The lowest was 2. And the median was 3.

CM Hospitalar  (BSP:VVEO3) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


CM Hospitalar Piotroski F-Score Related Terms


CM Hospitalar Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for CM Hospitalar's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CM Hospitalar Piotroski F-Score Chart

CM Hospitalar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 3.00 3.00 3.00 7.00

CM Hospitalar Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 3.00 3.00 7.00 8.00

BSP:VVEO3 vs MCK, COR, CAH: Piotroski F-Score Comparison

For the Medical Distribution subindustry, CM Hospitalar's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CM Hospitalar Piotroski F-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, CM Hospitalar's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where CM Hospitalar's Piotroski F-Score falls into.


BSP:VVEO3
70GF Score
CM Hospitalar SA BSP:VVEO3
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -71.358 + 226.877 + -78.346 + -57.008 = R$20 Mil.
Cash Flow from Operations was 130.42 + 81.304 + 171.141 + -47.807 = R$335 Mil.
Revenue was 2815.509 + 2833.653 + 3132.871 + 2831.92 = R$11,614 Mil.
Gross Profit was 422.451 + 415.63 + 447.062 + 446.479 = R$1,732 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(9371.027 + 9204.031 + 9063.534 + 8983.758 + 8963.502) / 5 = R$9117.1704 Mil.
Total Assets at the begining of this year (Mar25) was R$9,371 Mil.
Long-Term Debt & Capital Lease Obligation was R$2,801 Mil.
Total Current Assets was R$4,645 Mil.
Total Current Liabilities was R$3,500 Mil.
Net Income was -87.717 + -237.737 + -1093.08 + -58.934 = R$-1,477 Mil.

Revenue was 2747.167 + 2946.8 + 2936.805 + 2784.893 = R$11,416 Mil.
Gross Profit was 395.471 + 390.28 + 122.49 + 384.218 = R$1,292 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(11096.088 + 10525.811 + 10335.55 + 9545.108 + 9371.027) / 5 = R$10174.7168 Mil.
Total Assets at the begining of last year (Mar24) was R$11,096 Mil.
Long-Term Debt & Capital Lease Obligation was R$3,626 Mil.
Total Current Assets was R$5,160 Mil.
Total Current Liabilities was R$2,793 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

CM Hospitalar's current Net Income (TTM) was 20. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

CM Hospitalar's current Cash Flow from Operations (TTM) was 335. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=20.165/9371.027
=0.00215185

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-1477.468/11096.088
=-0.13315215

CM Hospitalar's return on assets of this year was 0.00215185. CM Hospitalar's return on assets of last year was -0.13315215. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

CM Hospitalar's current Net Income (TTM) was 20. CM Hospitalar's current Cash Flow from Operations (TTM) was 335. ==> 335 > 20 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=2800.995/9117.1704
=0.30722196

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=3626.078/10174.7168
=0.35638122

CM Hospitalar's gearing of this year was 0.30722196. CM Hospitalar's gearing of last year was 0.35638122. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=4644.819/3499.61
=1.32723904

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=5160.115/2793.118
=1.84743896

CM Hospitalar's current ratio of this year was 1.32723904. CM Hospitalar's current ratio of last year was 1.84743896. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

CM Hospitalar's number of shares in issue this year was 315.808. CM Hospitalar's number of shares in issue last year was 315.808. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1731.622/11613.953
=0.14909842

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1292.459/11415.665
=0.11321802

CM Hospitalar's gross margin of this year was 0.14909842. CM Hospitalar's gross margin of last year was 0.11321802. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=11613.953/9371.027
=1.23934687

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=11415.665/11096.088
=1.02880087

CM Hospitalar's asset turnover of this year was 1.23934687. CM Hospitalar's asset turnover of last year was 1.02880087. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+1+1+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

CM Hospitalar has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 8 mean?
CM Hospitalar (BSP:VVEO3) has a Piotroski F-Score of 8 as of Jun. 28, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on CM Hospitalar and its competitors. This is 167% above median its historical median of 3.00. Over the past decade, CM Hospitalar's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, CM Hospitalar ranks #3 out of 112 companies in the Medical Distribution industry, placing it in the top 2.7%.
Is CM Hospitalar's Piotroski F-Score too high?
CM Hospitalar's current Piotroski F-Score of 8 is 167% above median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Medical Distribution industry median Piotroski F-Score is 5.00. CM Hospitalar's value of 8 is 60% above this industry median. Based on the distribution chart, CM Hospitalar ranks #3 out of 112 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, CM Hospitalar has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CM Hospitalar's Piotroski F-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, CM Hospitalar ranks #3 out of 112 companies for Piotroski F-Score. This places CM Hospitalar in the top 3% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. CM Hospitalar's value of 8 is 60% above this benchmark. Historically, CM Hospitalar's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 5.00, CM Hospitalar has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Distribution company?
The median Piotroski F-Score among Medical Distribution companies is 5.00, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CM Hospitalar's current Piotroski F-Score of 8 is 60% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on CM Hospitalar and its competitors. For the Medical Distribution industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CM Hospitalar's current Piotroski F-Score is 8, which is 167% above median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CM Hospitalar stock overvalued right now?
Based on GuruFocus' analysis, CM Hospitalar (BSP:VVEO3) is currently considered Possible Value Trap. The stock's GF Value™ is R$1.99, compared to a current price of R$0.77 — trading 61.3% below its estimated fair value. The current Piotroski F-Score is 8, which is 167% above median its 10-year median of 3.00 and 60% above the Medical Distribution industry median of 5.00. CM Hospitalar's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For CM Hospitalar (BSP:VVEO3), the current Piotroski F-Score is 8 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CM Hospitalar (BSP:VVEO3) Overvalued in 2026?

Based on GuruFocus' analysis, CM Hospitalar stock appears to be undervalued. The current stock price of R$0.77 is trading 61.3% below its estimated GF Value™ of R$1.99. GuruFocus considers CM Hospitalar to be Possible Value Trap.

Key valuation signals for BSP:VVEO3:

  • Piotroski F-Score: 8 (167% above median its 10-year median of 3.00)
  • GF Value™: R$1.99 vs. price of R$0.77 (61.3% below fair value)
  • GF Score™: 70/100 with 6 warning signs
  • Industry Position: 60% above the Medical Distribution median (#3 of 112)

No single metric tells the full story. See the BSP:VVEO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CM Hospitalar Business Description

Address Avenue Luiz Maggioni, 2727, Distrito Empresarial Pref. Luiz Roberto Jabali, Ribeirao Preto, SP, BRA, 14072-055
CM Hospitalar SA is a distributor of hospital materials and medicines in the Brazilian market.
70GF Score

Get the complete analysis for BSP:VVEO3

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$0.77
Price
R$1.99
GF Value